MariMed Inc. (MRMD)

Ligand Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6.14	7.28	14.65	9.74	29.68	3
Short-Term Investments	-	-	0.09	0.12	0.25	1.36
Cash & Short-Term Investments	6.14	7.28	14.73	9.86	29.93	4.36
Cash Growth	-39.78%	-50.57%	49.42%	-67.06%	587.15%	99.11%
Accounts Receivable	7.69	8.74	7.2	4.16	1.67	6.68
Other Receivables	-	0.56	0.63	0.73	1.68	1.94
Receivables	7.73	9.35	7.88	7.53	3.47	9.27
Inventory	38.83	33.49	25.31	19.48	9.77	6.83
Other Current Assets	4.44	3.39	3.51	7.28	1.44	0.58
Total Current Assets	57.13	53.51	51.43	44.15	44.61	21.04
Property, Plant & Equipment	104.57	106.97	102.11	77.29	67.28	50.96
Long-Term Investments	-	-	0.22	-	-	1.17
Goodwill	20.05	15.81	11.99	8.08	2.07	2.07
Other Intangible Assets	20.72	18.64	17.01	14.2	0.16	0.16
Other Long-Term Assets	1.07	11.22	12.54	1.02	0.1	0.08
Total Assets	204.37	206.99	196.12	152.2	123.21	76.45
Accounts Payable	11.22	13.19	9	6.63	5.1	5.04
Accrued Expenses	7.41	4.44	3.55	3.09	3.15	3.78
Short-Term Debt	-	-	-	-	-	1.16
Current Portion of Long-Term Debt	3.42	5.13	0.72	3.77	1.41	11.28
Current Portion of Leases	3.45	4.01	3.16	1.51	1.1	1.05
Current Income Taxes Payable	25.44	21.92	14.43	11.49	16.47	0.9
Other Current Liabilities	-	-	-	-	-	0.02
Total Current Liabilities	50.94	48.68	30.86	26.49	27.22	23.23
Long-Term Debt	70.9	69.86	65.65	25.94	17.26	25.43
Long-Term Leases	9.26	9.48	10.6	4.63	4.6	4.87
Other Long-Term Liabilities	0.1	0.1	0.1	0.1	0.1	0.1
Total Liabilities	131.2	128.11	107.21	57.17	49.18	53.62
Common Stock	0.39	0.38	0.38	0.34	0.33	0.31
Additional Paid-In Capital	178.7	173.37	171.14	142.37	134.92	112.97
Retained Earnings	-118.84	-112.12	-99.96	-83.92	-97.39	-104.62
Comprehensive Income & Other	-	-	-	0.04	-	0.01
Total Common Equity	60.25	61.63	71.56	58.82	37.86	8.68
Minority Interest	-1.8	-1.75	-1.65	-1.51	-1.56	-0.58
Shareholders' Equity	73.17	78.88	88.91	95.04	74.02	22.83
Total Liabilities & Equity	204.37	206.99	196.12	152.2	123.21	76.45
Total Debt	87.03	88.47	80.13	35.86	24.37	43.78
Net Cash (Debt)	-80.89	-81.19	-65.39	-26	5.57	-39.42
Net Cash Per Share	-0.21	-0.21	-0.18	-0.07	0.01	-0.12
Filing Date Shares Outstanding	392.31	382.17	375.13	341.48	335.18	319.13
Total Common Shares Outstanding	392.01	381.48	375.13	341.47	334.03	314.42
Working Capital	6.19	4.83	20.57	17.66	17.39	-2.18
Book Value Per Share	0.15	0.16	0.19	0.17	0.11	0.03
Tangible Book Value	19.48	27.18	42.56	36.54	35.63	6.45
Tangible Book Value Per Share	0.05	0.07	0.11	0.11	0.11	0.02
Land	6.15	6.15	4.82	4.45	4.45	3.99
Buildings	56.7	55.83	54.74	43.54	35.23	29.31
Machinery	21.71	21.85	18.59	12.1	9.11	5.24
Construction In Progress	0.57	0.08	0.43	4.76	10.57	3.14
Leasehold Improvements	31.25	31.89	25.45	17.02	9.75	8.84

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.